Dr. Jason Cuéllar and Dr. Todd Lanman Contribute to FDA Approval of Two-Level Spinal Implants

Dr. Jason Cuéllar and Dr. Todd Lanman participated in the clinical trial that led to FDA approval of Centinel Spine’s prodisc C Vivo and prodisc C SK cervical disc replacement devices for two-level use. This approval marks a major step forward in motion-preserving spine surgery, expanding treatment options for patients with cervical disc disease.

The decision was supported by a 480-patient, 31-site clinical study—the largest ever conducted to support a PMA for a cervical total disc replacement system. The trial demonstrated an 87.1% composite clinical success rate, the highest reported for any approved two-level cervical system.

Their involvement underscores both surgeons’ continued commitment to advancing motion-preserving technologies and improving outcomes for patients worldwide.

Read the full article here.

More News & Insights from Cuéllar Spine

CONTACT US

Schedule a Consultation

    Dr. Cuéllar accepts most major insurance plans, but is an out of network provider. Please contact our team for more information.